MXene/Bi₂O₃ Nanocomposites as Supercapacitors for Portable Electronic Devices by Nanasaheb M. Shinde (8560572)

Subjects:

Numbers of deaths, mortality rates, and 95% confidence intervals by age group, disease stage, and sex in China in 2021. by Xinyue Qi (9637055)

Subjects:

Disability-adjusted life years (DALYs), age-standardized DALY rates (ASDR), and 95% confidence intervals by age group, disease stage, and sex in China in 2021. by Xinyue Qi (9637055)

Subjects:

Numbers of deaths and disability-adjusted life years (DALYs) by disease stage in China from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Deaths and DALYs from hepatitis B-related liver diseases in 1990 and 2021 and their change trends from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Age patterns by sex of the total number and age-specific DALYs rate. by Xinyue Qi (9637055)

Subjects:

Contribution of acute hepatitis B, cirrhosis and other chronic diseases due to hepatitis B and liver cancer due to hepatitis B to deaths and DALYs of total liver diseases due to he... by Xinyue Qi (9637055)

Subjects:

Mortality rates and disability-adjusted life years (DALYs) rates by disease stage, sex, and age groups (<35, 35–49, 50–69, ≥ 70, and all ages) in China from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Decomposition analysis of changes in hepatitis B virus (HBV) burden by region (China vs. Global), sex, and disease stage, 1990–2021. by Xinyue Qi (9637055)

Subjects:

Temporal trends of mortality of the total burden related to hepatitis B and three disease stages for all ages and across four age groups (<35, 35–49, 50–69, and ≥ 70 years) from 19... by Xinyue Qi (9637055)

Subjects:

Age patterns by sex of the total number and age-specific death rates in 2021. by Xinyue Qi (9637055)

Subjects:

Age-standardized mortality rates (ASMR), age-standardized disability-adjusted life year rates (ASDR), and their 95% uncertainty intervals (UIs) by disease stage in China from 1990... by Xinyue Qi (9637055)

Subjects:

BAPC model projections of mortality and DALYs rates for each disease stage in China from 2022 to 2035, with 50%, 60%, 70%, 80%, and 95% uncertainty intervals. by Xinyue Qi (9637055)

Subjects:

Temporal trends of DALYs of the total burden related to hepatitis B and three disease stages for all ages and across four age groups (<35, 35–49, 50–69, and ≥70 years) from 1990 to... by Xinyue Qi (9637055)

Subjects:

Decomposition analysis of changes in hepatitis B virus (HBV) burden by region (China vs. Global), sex, and disease stage, 1990 to 2021 (in Thousands). by Xinyue Qi (9637055)

Subjects:

Predictions for the annual age-standardized disability-adjusted life years (ASDR) attributable to hepatitis B virus (HBV) infection in China until 2035 on the basis of the Bayesian... by Xinyue Qi (9637055)

Subjects:

This diagram summarizes the main steps of our study, including data sourcing from the GBD 2021 database, stratified processing by disease stage, age, and sex, application of EAPC a... by Xinyue Qi (9637055)

Subjects:

Ba/F3 EML4-ALK^mutants exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

Subjects:

Summary of mean FB ratio distribution across racial groups. by Zoë Dinkel (21402766)

Subjects:

The composition of bacterial (A) and fungal (B) communities of the basal portion and bacterial (C) and fungal (D) communities of the apical portion under different treatments (n = ... by Bing-Nan Zhao (21553401)

Subjects: